INC Fundamental Analysis - INNOVATEC SPA

Fundamental Rating

Taking everything into account, INC scores 3 out of 10 in our fundamental rating. INC was compared to 70 industry peers in the Electrical Equipment industry. INC may be in some trouble as it scores bad on both profitability and health. INC is not valued too expensively and it also shows a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year INC has reported negative net income.

In the past year INC had a positive cash flow from operations.

Of the past 5 years INC 4 years were profitable.

INC had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

INC has a worse Return On Assets (-13.05%) than 80.00% of its industry peers.

INC has a Return On Equity of -98.27%. This is amonst the worse of the industry: INC underperforms 90.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-13.05%
ROE	-98.27%
ROIC	N/A

ROA(3y)0.36%

ROA(5y)1.03%

ROE(3y)-2.06%

ROE(5y)4.57%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 33.59%, INC is in line with its industry, outperforming 41.43% of the companies in the same industry.

INC's Gross Margin has improved in the last couple of years.

INC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	33.59%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.41%

GM growth 5Y5.98%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

INC does not have a ROIC to compare to the WACC, probably because it is not profitable.

INC has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for INC has been increased compared to 5 years ago.

INC has a better debt/assets ratio than last year.

2.2 Solvency

INC has an Altman-Z score of 1.50. This is a bad value and indicates that INC is not financially healthy and even has some risk of bankruptcy.

INC has a worse Altman-Z score (1.50) than 64.29% of its industry peers.

A Debt/Equity ratio of 0.38 indicates that INC is not too dependend on debt financing.

INC has a better Debt to Equity ratio (0.38) than 64.29% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	N/A
Altman-Z	1.5

ROIC/WACCN/A

WACC6.52%

2.3 Liquidity

INC has a Current Ratio of 0.98. This is a bad value and indicates that INC is not financially healthy enough and could expect problems in meeting its short term obligations.

INC's Current ratio of 0.98 is on the low side compared to the rest of the industry. INC is outperformed by 82.86% of its industry peers.

A Quick Ratio of 0.47 indicates that INC may have some problems paying its short term obligations.

INC has a Quick ratio of 0.47. This is amonst the worse of the industry: INC underperforms 92.86% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.98
Quick Ratio	0.47

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for INC have decreased strongly by -785.11% in the last year.

Looking at the last year, INC shows a very negative growth in Revenue. The Revenue has decreased by -48.14% in the last year.

Measured over the past years, INC shows a very strong growth in Revenue. The Revenue has been growing by 37.55% on average per year.

EPS 1Y (TTM)-785.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%61.54%

Revenue 1Y (TTM)-48.14%

Revenue growth 3Y15.33%

Revenue growth 5Y37.55%

Sales Q2Q%-89.43%

3.2 Future

Based on estimates for the next years, INC will show a very strong growth in Earnings Per Share. The EPS will grow by 58.11% on average per year.

Based on estimates for the next years, INC will show a quite strong growth in Revenue. The Revenue will grow by 12.42% on average per year.

EPS Next Y70%

EPS Next 2Y58.11%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year17.27%

Revenue Next 2Y17.48%

Revenue Next 3Y12.42%

Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INC. In the last year negative earnings were reported.

Based on the Price/Forward Earnings ratio of 0.95, the valuation of INC can be described as very cheap.

INC's Price/Forward Earnings ratio is rather cheap when compared to the industry. INC is cheaper than 100.00% of the companies in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 23.70. INC is valued rather cheaply when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	0.95

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INC indicates a rather cheap valuation: INC is cheaper than 98.57% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2.32

4.3 Compensation for Growth

INC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

INC's earnings are expected to grow with 58.11% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y58.11%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for INC!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

INNOVATEC SPA

BIT:INC (1/7/2026, 7:00:00 PM)

0.2405

+0 (+1.48%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.39%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap23.20M

Revenue(TTM)118.57M

Net Income(TTM)-9.32M

Analysts45.71

Price Target0.31 (28.9%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-83.33%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	0.95
P/S	0.2
P/FCF	N/A
P/OCF	2.44
P/B	2.45
P/tB	N/A
EV/EBITDA	2.32

EPS(TTM)-0.1

EYN/A

EPS(NY)0.25

Fwd EY104.99%

FCF(TTM)-0.16

FCFYN/A

OCF(TTM)0.1

OCFY40.94%

SpS1.23

BVpS0.1

TBVpS-0.01

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-13.05%
ROE	-98.27%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	33.59%
FCFM	N/A

ROA(3y)0.36%

ROA(5y)1.03%

ROE(3y)-2.06%

ROE(5y)4.57%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.41%

GM growth 5Y5.98%

F-Score6

Asset Turnover1.66

Health

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	N/A
Debt/EBITDA	0.34
Cap/Depr	149.03%
Cap/Sales	21.2%
Interest Coverage	N/A
Cash Conversion	88.94%
Profit Quality	N/A
Current Ratio	0.98
Quick Ratio	0.47
Altman-Z	1.5

F-Score6

WACC6.52%

ROIC/WACCN/A

Cap/Depr(3y)126.11%

Cap/Depr(5y)146.54%

Cap/Sales(3y)8.41%

Cap/Sales(5y)7.08%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-785.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%61.54%

EPS Next Y70%

EPS Next 2Y58.11%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-48.14%

Revenue growth 3Y15.33%

Revenue growth 5Y37.55%

Sales Q2Q%-89.43%

Revenue Next Year17.27%

Revenue Next 2Y17.48%

Revenue Next 3Y12.42%

Revenue Next 5YN/A

EBIT growth 1Y-144.83%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year135.95%

EBIT Next 3Y45.25%

EBIT Next 5YN/A

FCF growth 1Y-650.77%

FCF growth 3Y-41.71%

FCF growth 5Y-21.78%

OCF growth 1Y-38.94%

OCF growth 3Y8.36%

OCF growth 5Y14.62%

INNOVATEC SPA / INC.MI FAQ

What is the fundamental rating for INC stock?

ChartMill assigns a fundamental rating of 3 / 10 to INC.MI.

What is the valuation status for INC stock?

ChartMill assigns a valuation rating of 5 / 10 to INNOVATEC SPA (INC.MI). This can be considered as Fairly Valued.

What is the profitability of INC stock?

INNOVATEC SPA (INC.MI) has a profitability rating of 2 / 10.

How financially healthy is INNOVATEC SPA?

The financial health rating of INNOVATEC SPA (INC.MI) is 2 / 10.

INNOVATEC SPA (INC.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

INNOVATEC SPA / INC.MI FAQ

What is the fundamental rating for INC stock?

What is the valuation status for INC stock?

What is the profitability of INC stock?

How financially healthy is INNOVATEC SPA?